DVZ-22686-91728
1 vaccination
1 coded response
6 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 670 / KS
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Registered in v-safe
-
2021-03-31
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-31
-
2021-04-01
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-03
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-09-29
-
2022-03-31
Survey response — 12 months, dose 1MedDRA: COVID-19, Stillbirth — Feeling: Good · Be unable to do your normal daily activitiesFree text: Had a stillbirth. Was told it was because I contracted COVID even after being vaccinated. Had no COVID symptoms.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Janssen/Johnson & Johnson |
Free text
Release 11 — 12 months, dose 1
Symptoms: Had a stillbirth. Was told it was because I contracted COVID even after being vaccinated. Had no COVID symptoms.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Stillbirth | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release